Skip to main content

Table 2 Median Likert responses of statements that expedited symptomatic cancer diagnosis brings mortality or morbidity benefits

From: For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique

  Expedited symptomatic cancer diagnosis brings mortality benefits Expedited symptomatic cancer diagnosis brings morbidity benefits
Strongly agree   
Agree Bladder, breast, cervix, colon, larynx, lung, melanoma, ovary, rectum, testis, uterus Bladder, brain, colon, kidney, larynx, leukaemia, lung, myeloma, oesophagus, ovary, stomach
Undecided Hodgkin’s disease, kidney, leukaemia, myeloma, non-Hodgkin’s lymphoma, oesophagus, ovary, stomach Breast, cervix, Hodgkin’s disease, melanoma, non-Hodgkin’s lymphoma, pancreas, prostate, rectum, testis, uterus
Disagree Brain, pancreas, prostate  
Strongly disagree   
  1. Note: the median response for ovary and mortality was between ‘agree’ and ‘undecided’ – thus we have placed it in both cells.